bioMérieux S.A. (EPA:BIM)
69.35
-0.45 (-0.64%)
Apr 29, 2026, 2:35 PM CET
bioMérieux Revenue
In the year 2025, bioMérieux had annual revenue of 4.07B EUR with 2.26% growth. bioMérieux had revenue of 2.03B in the half year ending December 31, 2025, with 6.37% growth.
Revenue
4.07B
Revenue Growth
+2.26%
P/S Ratio
2.02
Revenue / Employee
273.25K
Employees
15,226
Market Cap
8.23B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.07B | 89.90M | 2.26% |
| Dec 31, 2024 | 3.98B | 305.20M | 8.31% |
| Dec 31, 2023 | 3.67B | 85.60M | 2.39% |
| Dec 31, 2022 | 3.59B | 212.90M | 6.31% |
| Dec 31, 2021 | 3.38B | 258.00M | 8.27% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sanofi | 46.72B |
| EssilorLuxottica Société anonyme | 28.49B |
| Sartorius Stedim Biotech | 2.98B |
| Ipsen | 3.93B |
| Eurofins Scientific SE | 7.30B |
| ABIVAX Société Anonyme | 4.57M |
| Virbac | 1.46B |
| emeis Société anonyme | 5.90B |
bioMérieux News
- 6 days ago - bioMérieux Earnings Call Transcript: Q1 2026 - Transcripts
- 6 days ago - BioMerieux Q1 Sales Down 3.9% On Organic Basis; Revises 2026 Guidance - Nasdaq
- 2 months ago - bioMérieux Earnings Call Transcript: H2 2025 - Transcripts
- 6 months ago - bioMérieux Earnings Call Transcript: Q3 2025 - Transcripts
- 8 months ago - bioMérieux Earnings Call Transcript: H1 2025 - Transcripts
- 1 year ago - bioMérieux Earnings Call Transcript: Q1 2025 - Transcripts
- 1 year ago - bioMérieux Earnings Call Transcript: H2 2024 - Transcripts
- 1 year ago - bioMérieux Transcript: 43rd Annual J.P. Morgan Healthcare Conference 2025 - Transcripts